These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26550791)

  • 21. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.
    Hao M; Li SY; Sun CK; Jingyu-Xu ; Lin Y; Liu KX; Wang L; Li CX; Zhou Q; Du JL; Li H
    Eur J Pharmacol; 2011 Mar; 654(3):320-5. PubMed ID: 21236251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyphenols of Myrica faya inhibit key enzymes linked to type II diabetes and obesity and formation of advanced glycation end-products (in vitro): Potential role in the prevention of diabetic complications.
    Spínola V; Llorent-Martínez EJ; Castilho PC
    Food Res Int; 2019 Feb; 116():1229-1238. PubMed ID: 30716910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycation, carbonyl stress and AGEs inhibitors: a patent review.
    Jahan H; Choudhary MI
    Expert Opin Ther Pat; 2015; 25(11):1267-84. PubMed ID: 26293545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted benzenediol Schiff bases as promising new anti-glycation agents.
    Choudhary MI; Abbas G; Ali S; Shuja S; Khalid N; Khan KM; Atta-ur-Rahman ; Basha FZ
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):98-103. PubMed ID: 20583858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats.
    Jagtap AG; Patil PB
    Food Chem Toxicol; 2010; 48(8-9):2030-6. PubMed ID: 20451573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity.
    Zhang X; Hu S; Chen F; Wang M
    Food Funct; 2014 Oct; 5(10):2656-61. PubMed ID: 25208810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of AGEs formation by natural products.
    Nagai R; Shirakawa J; Ohno R; Moroishi N; Nagai M
    Amino Acids; 2014 Feb; 46(2):261-6. PubMed ID: 23504149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Glycation Effects of Pomegranate (Punica granatum L.) Fruit Extract and Its Components in Vivo and in Vitro.
    Kumagai Y; Nakatani S; Onodera H; Nagatomo A; Nishida N; Matsuura Y; Kobata K; Wada M
    J Agric Food Chem; 2015 Sep; 63(35):7760-4. PubMed ID: 26242637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
    Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the traditional Brazilian drink Ilex paraguariensis tea on glucose homeostasis.
    Pereira DF; Kappel VD; Cazarolli LH; Boligon AA; Athayde ML; Guesser SM; Da Silva EL; Silva FR
    Phytomedicine; 2012 Jul; 19(10):868-77. PubMed ID: 22795927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications.
    Beisswenger PJ
    Biochem Soc Trans; 2014 Apr; 42(2):450-6. PubMed ID: 24646259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract.
    Choi SY; Jung SH; Lee HS; Park KW; Yun BS; Lee KW
    Phytother Res; 2008 Mar; 22(3):323-9. PubMed ID: 18167045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonyl stress and diabetic complications.
    Miyata T; Ishikawa N; van Ypersele de Strihou C
    Clin Chem Lab Med; 2003 Sep; 41(9):1150-8. PubMed ID: 14598864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end-products and the kidney.
    Busch M; Franke S; Rüster C; Wolf G
    Eur J Clin Invest; 2010 Aug; 40(8):742-55. PubMed ID: 20649640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.
    Mengstie MA; Chekol Abebe E; Behaile Teklemariam A; Tilahun Mulu A; Agidew MM; Teshome Azezew M; Zewde EA; Agegnehu Teshome A
    Front Mol Biosci; 2022; 9():1002710. PubMed ID: 36188225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.
    Aldini G; Vistoli G; Stefek M; Chondrogianni N; Grune T; Sereikaite J; Sadowska-Bartosz I; Bartosz G
    Free Radic Res; 2013 Aug; 47 Suppl 1():93-137. PubMed ID: 23560617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.
    Yamagishi S; Nakamura K; Matsui T; Ueda S; Noda Y; Imaizumi T
    Cardiovasc Ther; 2008; 26(1):50-8. PubMed ID: 18466420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.